The forecast for hospital discharges for malignant neoplasm of skin in France shows a gradual decline from 2024 to 2028, decreasing from 24.7 to 22.0 discharges per 100,000 individuals. This represents a yearly decrease, with the compounded annual growth rate (CAGR) of approximately -3% over these years. Compared to 2023, the series reflects a consistent downtrend, indicative of potential improvements in early detection or preventive measures instituted prior to 2024.
Future trends to watch for include advancements in skin cancer prevention and treatment technologies, changes in environmental factors such as UV exposure, and shifts in healthcare policies that could further impact hospital discharge rates for skin-related malignancies.
